Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis
- 23 December 2016
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 162 (2) , 201-215
Abstract
Purpose New indications have been found for regional nodal irradiation (RNI) in breast cancer treatment, yet the relationship of RNI and lymphedema risk is uncertain. We sought to determine the association of RNI and lymphedema. Methods We searched MEDLINE, EMBASE, and Scopus for articles in English on humans published from 1995 to 2015, using search terms breast neoplasm, treatment, and morbidity. Two investigators independently selected articles and extracted information, including manuscripts reporting incidence of lymphedema by radiation targets. Meta-analyses, review papers, case–control studies, matched-pair studies, repetitive datasets, and retrospective studies were excluded. A total of 2399 abstracts were identified and 323 corresponding articles reviewed. Twenty-one studies met inclusion criteria. Data were pooled using a random effects mixed model. Network meta-analyses were performed to determine the association of radiation targets alone and radiation targets plus extent of axillary surgery on incidence of lymphedema. Results The addition of RNI to breast/CW irradiation was associated with an increased incidence of lymphedema (OR 2.85; 95% CI 1.24–6.55). In patients treated with sentinel lymph node biopsy or axillary sampling, there was no association of lymphedema with the addition of RNI to breast/CW irradiation (OR 1.58; 95% CI 0.54–4.66; pooled incidence 5.7 and 4.1%, respectively). Among patients treated with axillary lymph node dissection (ALND), treatment with RNI in addition to breast/CW radiation was associated with a significantly higher risk of lymphedema (OR 2.74; 95% CI 1.38–5.44; pooled incidence 18.2 and 9.4%, respectively). Conclusions RNI is associated with a significantly higher risk of lymphedema than irradiation of the breast/CW, particularly after ALND.Keywords
Funding Information
- There was no funding for the work provided.
This publication has 45 references indexed in Scilit:
- Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomesJournal of Cancer Survivorship, 2012
- Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27Journal of Clinical Oncology, 2012
- Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodologyBreast Cancer Research and Treatment, 2012
- Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health StudyBreast Cancer Research and Treatment, 2011
- Standardized Method for Quantification of Developing Lymphedema in Patients Treated for Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- Life after Breast Cancer: Dealing with LymphoedemaClinical Medicine Insights: Oncology, 2011
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialThe Lancet Oncology, 2010
- Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage i. results from a randomised trialEuropean Journal of Cancer, 1997
- Lymphedema complicated by pain and psychological distress: A case with complex treatment needsJournal of Pain and Symptom Management, 1996